Adaptimmune Therapeutics PLC ADAP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
1.56quote price arrow down-0.02 (-1.27%)
Volume
2,874
Close
1.58UNCH (UNCH)
Volume
1,062,044
52 week range
0.42 - 2.05
Loading...
  • Open1.65
  • Day High1.65
  • Day Low1.53
  • Prev Close1.58
  • 52 Week High2.05
  • 52 Week High Date03/08/24
  • 52 Week Low0.42
  • 52 Week Low Date11/21/23

Key Stats

  • Market Cap389.984M
  • Shares Out246.83M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta2.38
  • YTD % Change99.24

KEY STATS

  • Open1.65
  • Day High1.65
  • Day Low1.53
  • Prev Close1.58
  • 52 Week High2.05
  • 52 Week High Date03/08/24
  • 52 Week Low0.42
  • 52 Week Low Date11/21/23
  • Market Cap389.984M
  • Shares Out246.83M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta2.38
  • YTD % Change99.24

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-3.03
  • Fwd P/E (NTM)-4.70
  • EBITDA (TTM)-128.198M
  • ROE (TTM)-187.61%
  • Revenue (TTM)60.281M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-188.90%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adaptimmune Therapeutics PLC

 

Profile

MORE
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. It develops T-cell therapies for solid tumors and has reported responses in multiple solid tumor indications. Its platform helps to identify cancer targets, find and develop cell therapy candidates active against those targets and produce therapeutic candidates for administration to patients. Its cell therapy candidates include...
David Mott
Non-Executive Independent Chairman of the Board
Adrian Rawcliffe
Chief Executive Officer, Director
William Bertrand Jr., Esq.
Chief Operating Officer
Gavin Wood
Chief Financial Officer
Address
60 Jubilee Avenue, Milton Park
Abingdon
OX14 4RX
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
ACLX
Arcellx Inc
69.55UNCHUNCH
SWTX
SpringWorks Therapeutics Inc
49.22UNCHUNCH
IBRX
Immunitybio Inc
5.37UNCHUNCH
IOVA
Iovance Biotherapeutics Inc
14.82UNCHUNCH
CRNX
Crinetics Pharmaceuticals Inc
46.81UNCHUNCH